Literature DB >> 27366422

Anaesthetic Management of a Patient with Hereditary Angioedema.

Mediha Türktan1, Ersel Güleç1, Zehra Hatipoğlu1, Çağatay Küçükbingöz1, Mustafa Yılmaz2, Yasemin Güneş1.   

Abstract

Hereditary angioedema (HAE) is a rare autosomal dominant disorder caused by reduced activity of the C1 esterase inhibitor. Clinically, angioedema most often involves the upper extremities, face, neck and larynx. The most common cause of death is asphyxia related to laryngeal oedema. Attacks are triggered by many factors such as trauma, stress, infections and hormonal fluctuations. C1 esterase inhibitor concentrates, fresh frozen plasma (FFP), androgen steroids, quinine pathway inhibitors and antifibrinolytics can be used as treatment. In this case report, the anaesthetic management of a patient with hereditary angioedema undergoing laminectomy surgery is reported.

Entities:  

Keywords:  C1 esterase inhibitor; Hereditary angioedema; laminectomy

Year:  2014        PMID: 27366422      PMCID: PMC4894150          DOI: 10.5152/TJAR.2014.44712

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  15 in total

1.  Hereditary angioneurotic edema. I. Case reports and review of the literature.

Authors:  N S LANDERMAN
Journal:  J Allergy       Date:  1962 Jul-Aug

2.  Hereditary angioedema.

Authors:  M Cicardi; A Agostoni
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

3.  Hereditary angioedema: report of case.

Authors:  K M Phillips; M Glick; S G Cohen
Journal:  Spec Care Dentist       Date:  1989 Jan-Feb

4.  Hereditary angioneurotic oedema, tracheal intubation and airway obstruction.

Authors:  P M Spargo; G B Smith
Journal:  Can J Anaesth       Date:  1987-09       Impact factor: 5.063

5.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema.

Authors:  Konrad Bork; Gabriele Meng; Petra Staubach; Jochen Hardt
Journal:  Transfusion       Date:  2005-11       Impact factor: 3.157

6.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Authors:  Marco Cicardi; Aleena Banerji; Francisco Bracho; Alejandro Malbrán; Bernd Rosenkranz; Marc Riedl; Konrad Bork; William Lumry; Werner Aberer; Henning Bier; Murat Bas; Jens Greve; Thomas K Hoffmann; Henriette Farkas; Avner Reshef; Bruce Ritchie; William Yang; Jürgen Grabbe; Shmuel Kivity; Wolfhart Kreuz; Robyn J Levy; Thomas Luger; Krystyna Obtulowicz; Peter Schmid-Grendelmeier; Christian Bull; Brigita Sitkauskiene; William B Smith; Elias Toubi; Sonja Werner; Suresh Anné; Janne Björkander; Laurence Bouillet; Enrico Cillari; David Hurewitz; Kraig W Jacobson; Constance H Katelaris; Marcus Maurer; Hans Merk; Jonathan A Bernstein; Conleth Feighery; Bernard Floccard; Gerald Gleich; Jacques Hébert; Martin Kaatz; Paul Keith; Charles H Kirkpatrick; David Langton; Ludovic Martin; Christiane Pichler; David Resnick; Duane Wombolt; Diego S Fernández Romero; Andrea Zanichelli; Francesco Arcoleo; Jochen Knolle; Irina Kravec; Liying Dong; Jens Zimmermann; Kimberly Rosen; Wing-Tze Fan
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

7.  How do we treat patients with hereditary angioedema.

Authors:  Marco Cicardi; Lorenza Zingale
Journal:  Transfus Apher Sci       Date:  2003-12       Impact factor: 1.764

8.  C1-esterase inhibitor transfusions in patients with hereditary angioedema.

Authors:  D E Visentin; W H Yang; J Karsh
Journal:  Ann Allergy Asthma Immunol       Date:  1998-06       Impact factor: 6.347

9.  Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients.

Authors:  A Agostoni; M Cicardi
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

10.  Oral manifestations and dental management of patients with hereditary angioedema.

Authors:  J C Atkinson; M M Frank
Journal:  J Oral Pathol Med       Date:  1991-03       Impact factor: 4.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.